E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression. Wang et al.
Published: 21 January 2022| Version 1 | DOI: 10.17632/gdcgx46ht8.1
Contributor:
Ying LiuDescription
This is the original data set for our study entitled "E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression"
Files
Institutions
Peking University
Categories
Life Sciences, Mammalian Target of Rapamycin, Ubiquitylation